3rd Forum on Clinical Trial Registries and Results Databases

I would like to extend you one final invitation to join me at The Center for Business Intelligence'. As clinical trial transparency continues to evolve globally, CBI has been at the forefront of providing expert insights on the ever-changing compliance and regulatory guidelines surrounding national registries and results databases. Our upcoming annual forum, in its 3rd year, boasts our strongest program and speaker faculty to date.

In recent years, the need for increased clinical trial transparency has been addressed head-on by key regulatory bodies through varying trial registration and results posting requirements.  Additionally, national registries continue to emerge globally with individual guidelines for compliance.  The ability to manage these complex requirements is essential for every company’s success.  At this forum, those who are responsible for maintaining clinical trial transparency discuss shared challenges and learn best practices for managing these ever-changing processes. 

Topics to be Addressed Include:

• Adjusting for the EudraCT Database Updates
• Implications of the Proposed EudraCT Results Databases
• Status of IFPMA Positions Supporting Transparency
• Implications for Reporting Results of Unapproved Products
• Results Posting and the Effect on Publication Planning
• Successful Implementation of Results Posting into Business Operations
• The Importance of Registries from a Patient Advocacy Perspective 
• Examining Registry Initiatives in Other Countries

Hear unique perspectives from leading organisations, such as Abbott Labs, F. Hoffmann-La Roche, GSK, Ipsen, ITPC, J&J, Novartis, Novo Nordisk and UBC on the most pressing, hot-button topics, including:

• What the EMA is proposing to collect and make public
• Implications of reporting study results for unapproved products and unintended consequences
• Challenges of adapting requirements
• IFPMA implementations
• Relationship between publicly available information and proprietary information
• Mandatory vs. voluntary emerging registries

Who Should Attend
You will benefit from this event if you are a Vice President or Director/Manager at a pharmaceutical, biotech or medical device company with responsibilities in the following areas:

• Regulatory Affairs
• Clinical Trial Registries
• Disclosure
• Medical Information
• Clinical Research
• Medical Affairs
• Medical Business Operations
• Policy
• Clinical Trials
• Publication Planning
• Medical Writing
• Clinical Trial Information
• Clinical Affairs
• Clinical Communications/ Marketing
• Clinical Operations
• Clinical Science
• Business Development
• Drug Safety
• Global Development
• Information Management
• Outcomes Research
• Patient Recruitment
• Project Management
• Strategic Operations/Planning
• Worldwide Development

This conference will also interest contract research organizations, registries and results databases and technology vendors who implement registries and databases.

Don't miss the opportunity to join your colleagues at the industry's finest event dedicated to Clinical Trial Registries and Results Databases!
Register online at www.cbinet.com/ctrreu. 

For more information about the conference, please contact Suzanne Thelen at 339-298-2104 or email her at Suzanne.Thelen@cbinet.com.